Dolby International v Epson France (CFI, 27 May 2025)
| Date | 27 May 2025 |
|---|---|
| Court | CFI |
| Division | Hamburg (DE) Local Division |
| Type of action | Preliminary objection |
| Registry reference | App_16032/2025 · ORD_18316/2025 |
| Parties | Dolby International AB v. Epson France SAS |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By order of 27 May 2025, the judge rapporteur of the Hamburg Local Division rejected the preliminary objection to jurisdiction raised by Epson France in Dolby International’s infringement action on EP 3 605 534 against five Epson companies (UPC_CFI_77/2025). The withdrawal of the opt-out, declared on 23 January 2024, applies to all States of the patent, even though only some appeared in the case management system. Leave to appeal was refused.
Question
Was the withdrawal of the opt-out limited to the six States (Germany, Spain, France, the United Kingdom, Italy and the Netherlands) where the patent remained in force, excluding Belgium, Luxembourg and Ireland, so that the UPC lacked jurisdiction?
Decision
No. The objection, which was admissible, was decided at once under Rule 20.1, jurisdiction being a fundamental procedural question. The form used contains all the fields required by Rule 5.3. The States mentioned appear only in connection with the proprietor, since the system automatically lists all States of grant. Rule 5.7 prohibits distinguishing between States, so a partial withdrawal would be contrary to the Rules, and Rule 5.3(c) requires only the patent details, not a list of States (section 1). The « correction » of 21 March 2025 is merely a clarification. Whether it came too late in relation to the national revocation action is irrelevant. Leave to appeal was refused, the question not being of general significance (section 2).
Key points for practice
- An opt-out withdrawal cannot be partial: it covers the patent for all States, whatever list the case management system displays.
- The judge rapporteur may decide a preliminary objection as soon as it is lodged where jurisdiction is at stake.
Provisions applied
- Agreement on a Unified Patent Court
- Art. 83(3)
- Rules of Procedure
- Rules 4.1, 5.1(b), 5.3(a) and (c), 5.7, 19.1(a), 20.1, 21.1 and 220.2
- Case law cited
- BioMarin v Ascendis, Munich Local Division, 2 April 2025
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: Local and central divisions (UPC).
Dhenne Avocats blog: The Transitional Period and the UPC: Coordinating Two Judicial Orders.
Publications by Matthieu Dhenne: Pleading the Long Arm: What a UPC Statement of Claim Must Carry Beyond Jurisdiction, Valeo v. Bosch and the Redistribution of Cases Within the UPC (Kluwer Patent Blog).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
Parties
- claimantDolby International AB35 decisions in the corpusFollow this party
- defendantEpson France SASFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Preliminary objection
- Outcome (Dhenne Avocats summary)
- L'exception préliminaire d'Epson France est rejetée : le retrait de l'opt-out vaut pour tous les États du brevet, la règle 5.7 excluant toute distinction entre États, l'instance se poursuit et l'appel n'est pas autorisé.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 3 605 534mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- BioMarin Pharmaceutical v Ascendis Pharma (CFI, 2 April 2025) cited in this record
Patents and standards
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.